Press review
The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.
PsychiatryWho is afraid of Christmas? Do holidays trigger psychiatric crises?
By Carolina Lima | Published on Décember 4, 2025 | 3 min readWhen we think about Christmas or Easter, we imagine joy, family dinners, and cozy traditions. Yet, for many individuals, this period can bring unique psychological challenges. For mental health professionals, these periods often raise a question: do holidays increase psychiatric emergencies? Surprisingly, recent findings show the opposit
InfectiologyTwice-yearly injections to change the game?
By Ana Espino | Published on December 3rd, 2025 | 3 min readHIV remains a major global challenge, with more than 1.3 million new infections recorded in 2024, particularly affecting marginalized populations. Although oral pre-exposure prophylaxis (PrEP) has proven effective, its real-world impact is limited by adherence barriers such as stigma, daily pill fatigue, and inconsistent access to care. S
InfectiologyHIV & young people: what if we changed the rules?
By Ana Espino | Published on December 2nd, 2025 | 2 min readHuman Immunodeficiency Virus (HIV) remains a major public health issue, especially in high-prevalence countries where it continues to cause substantial morbidity and mortality. Young people—particularly young women—represent an especially vulnerable population. They often struggle to access appropriate health services, and many avoid test
InfectiologyHDL: an ally going off track?
By Ana Espino | Published on December 2nd, 2025 | 3 min readChronic HIV infection, even when well controlled by antiretroviral therapy, is associated with an increased cardiometabolic risk, including higher rates of cardiovascular events, hypertension, insulin resistance, and dyslipidemia. This elevated risk cannot be explained solely by traditional factors, but also by persistent immunometabolic
OncologyWill biomarkers save patients with refractory testicular germ cell tumors?
By Lila Rouland | Published on December 1rst, 2025 | 3 min readMetastatic testicular germ cell tumors (TGCTs) currently achieve high cure rates with cisplatin-based chemotherapy; however, 20–30% of patients relapse or exhibit resistance to first-line treatment. For those facing refractory or relapsed disease, the identification of prognostic and predictive biomarkers is becoming essential to optim
OncologyTesticular Germ Cell Tumors: epidemiology, risk factors, and advances in management
By Carolina Lima | Published on November 28, 2025 | 3 min readTesticular germ cell tumors (TGCTs) represent the most common malignancy in young men aged 15–40 years, accounting for approximately 95% of all testicular cancers. They arise from germ cells and are classified as seminomas or non-seminomatous tumors (NSGCTs), each requiring distinct treatment strategies. Despite their rarity in the gene
OncologymHSPC: the winning trio?
By Ana Espino | Published on November 27, 2025 | 3 min readMetastatic hormone-sensitive prostate cancer (mHSPC) is an advanced stage of the disease, with a prognosis that remains concerning despite recent therapeutic advances. Standard treatment is based on androgen deprivation therapy (ADT), to which agents such as docetaxel or androgen receptor–targeted therapies (ARATs)—including enzalutamide,
OncologyTesticular cancer: Does the future remain fertile?
By Ana Espino | Published on November 26, 2025 | 3 min readTesticular cancer is the most common solid tumor in young men and carries an excellent prognosis thanks to current treatments such as surgery, chemotherapy, and radiotherapy. However, fertility preservation remains a major concern, as these treatments can impair spermatogenesis, either temporarily or permanently. This study was initiated t
OncologyNutrition: a hidden ally in cancer treatments?
By Ana Espino | Published on November 25, 2025 | 3 min readCancer treatment, whether based on chemotherapy, radiotherapy, or immunotherapy, is frequently associated with gastrointestinal side effects. These digestive symptoms have a direct impact on patients’ nutritional status and may compromise the effectiveness of oncological treatments. Conventional approaches aimed at reducing these side effe
OncologyRadium-223: a winning duo with enzalutamide?
By Ana Espino | Published on November 25, 2025 | 2 min readMetastatic castration-resistant prostate cancer (mCRPC) represents an advanced and aggressive stage of the disease in which tumor cells continue to progress despite androgen suppression. It is characterized in most cases by bone metastases, which are responsible for considerable morbidity and increased mortality. These bone lesions expose
Endocrinology and MetabolismDoes smoking during pregnancy protect against type 1 diabetes?
By Ana Espino | Published on November 24, 2025 | 3 min read Type 1 diabetes (T1D) is a chronic autoimmune disease caused by the destruction of the β-cells of the pancreatic islets of Langerhans, leading to lifelong dependence on insulin. Its global prevalence is steadily increasing, particularly in developed countries, making T1D a major public health concern due to its metabolic and psychosocial
Urology-nephrologyNeuroSAFE-assisted surgery: a lever to preserve continence and erectile function after prostatectomy?
By Lila Rouland | Published on November 24, 2025 | 3 min readRadical prostatectomy (RP) remains a key treatment for men with localized prostate cancer. However, it is associated with two major side effects: urinary incontinence and erectile dysfunction, both of which significantly affect postoperative quality of life. Nerve-sparing (NS) techniques allow partial preservation of erectile nerves to l